Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Xu, W. Tang, J. Chen, C. Wang, C. Wen, W. Cheng, Y. Zhou, M. Wu, Q. Zhang, X. Feng, Z. Wang, M.

Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Katoto, P. D. M. C. Brand, A. S. Byamungu, L. N. Tamuzi, J. L. Mahwire, T. C. Kitenge, M. K. Wiysonge, C. S. Gray, G.

Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis

  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, H. Zhang, X. Lin, G. Gong, F. Hocher, B.

Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review

  • Western Pacific
  • China
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Zheng, Q. Ma, P. Feng, Z.

Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ James, D. Jena, A. Bharath, P. N. Choudhury, A. Singh, A. K. Sebastian, S. Sharma, V.

Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2022 ∙ Asghar, N. Mumtaz, H. Syed, A. A. Eqbal, F. Maharjan, R. Bamboria, A. Shrehta, M.

Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Tian, Y. Chen, L. Shi, Y.

Safety, Efficacy, and Immunogenicity of Varying Types of COVID-19 Vaccines in Children Younger Than 18 Years: An Update of Systematic Review and Meta-Analysis

  • Newborn
  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2022 ∙ Du, Y. Chen, L. Shi, Y.

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis

  • Children
  • Adolescents
  • COVID-19
  • Safety
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2022 ∙ Ledda, C. Costantino, C. Motta, G. Cunsolo, R. Stracquadanio, P. Liberti, G. Maltezou, H. C. Rapisarda, V.

SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review

  • Healthcare workers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Ssentongo, P. Ssentongo, A. E. Voleti, N. Groff, D. Sun, A. Ba, D. M. Nunez, J. Parent, L. J. Chinchilli, V. M. Paules, C. I.

SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...